- Home
- ISPC vs PPBT Comparison
ISPC vs PPBT Comparison
Compare ISPC & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ISPC | PPBT |
|---|---|---|
| Founded | 2009 | 2010 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 4.4M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ISPC | PPBT |
|---|---|---|
| Price | $3.13 | $2.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $30.00 |
| AVG Volume (30 Days) | ★ 205.8K | 39.1K |
| Earning Date | 05-18-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 87.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,928,998.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.10 | $0.41 |
| 52 Week High | $6.77 | $5.18 |
Technical Indicators
Market Signals| Indicator | ISPC | PPBT |
|---|---|---|
| Relative Strength Index (RSI) | 48.42 | 38.89 |
| Support Level | $0.37 | $0.57 |
| Resistance Level | $4.49 | $4.39 |
| Average True Range (ATR) | 0.39 | 0.28 |
| MACD | -0.21 | -0.01 |
| Stochastic Oscillator | 16.35 | 31.37 |
Price Performance
Historical ComparisonAbout ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.